NSAIDs raise potassium levels by blocking the production of signaling molecules in the kidneys that normally trigger the release of renin, a hormone essential for potassium excretion. This sets off a chain reaction: less renin means less aldosterone, and less aldosterone means your kidneys hold onto potassium instead of flushing it into your urine. Hyperkalemia is defined as a serum potassium level above 5.2 mEq/L, and NSAIDs are listed alongside ACE inhibitors, ARBs, and potassium-sparing diuretics as drugs that can push you past that threshold.
The Prostaglandin-Renin Connection
To understand how NSAIDs cause hyperkalemia, you need to follow the dominoes. It starts with prostaglandins, specifically two types called PGE2 and PGI2. These are produced in the kidneys and act directly on specialized cells called juxtaglomerular cells, which sit along the blood vessels feeding into the kidney’s filtering units. Prostaglandins stimulate these cells to release renin into the bloodstream.
The mechanism is well understood at the cellular level. PGE2 and PGI2 bind to receptors on juxtaglomerular cells and trigger a rise in a signaling molecule called cAMP inside those cells. That cAMP signal is the direct trigger for renin to be packaged and released. Research published in the American Journal of Physiology confirmed that this effect is a direct cellular action, not an indirect consequence of changes in blood flow or pressure. Both prostaglandins stimulated renin release and increased renin gene activity in isolated juxtaglomerular cells.
NSAIDs work by blocking cyclooxygenase enzymes (COX-1 and COX-2), which are the enzymes responsible for making prostaglandins throughout the body. That’s how they reduce pain and inflammation. But in the kidneys, blocking COX enzymes, particularly COX-2, shuts down prostaglandin production in the juxtaglomerular cells. Without that prostaglandin signal, renin secretion drops. Studies using both pharmacological COX-2 blockers and genetic deletion of COX-2 in animal models consistently show suppressed renin release.
From Low Renin to High Potassium
Renin is the first step in a hormonal cascade called the renin-angiotensin-aldosterone system. Renin converts a precursor protein into angiotensin I, which is then converted into angiotensin II, which in turn stimulates the adrenal glands to produce aldosterone. When NSAIDs suppress renin, the entire downstream chain weakens. The result is a state sometimes called hyporeninemic hypoaldosteronism: low renin and, consequently, low aldosterone.
Aldosterone is the hormone that tells the collecting ducts in your kidneys to excrete potassium. It does this by activating sodium channels and potassium channels in the cells lining those ducts. Sodium gets reabsorbed back into the body, and potassium gets secreted into the urine. When aldosterone levels are low, this exchange slows down. Your kidneys reabsorb less sodium and, more importantly for hyperkalemia, excrete less potassium. Potassium accumulates in the blood.
Reduced Kidney Blood Flow Adds to the Problem
Prostaglandins also play a separate role in maintaining blood flow to the kidneys. They dilate the blood vessels feeding the kidney’s filtering units, especially under conditions of stress like dehydration, heart failure, or existing kidney disease. When NSAIDs block prostaglandin production, those vessels constrict. Less blood reaches the kidneys, and the overall filtration rate drops.
A lower filtration rate means less fluid passing through the nephrons, which are the tiny tubes where potassium excretion actually happens. Even if aldosterone levels were normal, reduced flow through the nephrons would limit how much potassium can be carried out. The combination of lower aldosterone and reduced kidney perfusion makes the effect on potassium worse than either mechanism alone.
Not All NSAIDs Carry Equal Risk
A nested case-control study examining dispensed NSAIDs and hyperkalemia risk found significant variation between individual drugs. Indomethacin and rofecoxib (a COX-2 selective inhibitor now withdrawn from the market) both showed elevated risk, with odds ratios of 1.36 and 1.37 respectively. Celecoxib and diclofenac also carried higher risk. Meanwhile, ibuprofen, naproxen, meloxicam, piroxicam, sulindac, etodolac, and ketorolac did not show a statistically elevated risk of moderate to severe hyperkalemia.
One surprising finding: the difference in risk between NSAIDs does not appear to depend on whether a drug is COX-2 selective or nonselective. Both categories included higher-risk and lower-risk drugs. The researchers suggested that the risk may depend more on concurrent medications and individual patient factors than on the COX selectivity profile of the NSAID itself.
Who Is Most Vulnerable
In a person with healthy kidneys, normal hydration, and no other medications affecting potassium, NSAIDs are unlikely to cause dangerous hyperkalemia on their own. The body has backup mechanisms for managing potassium. The real danger emerges when multiple risk factors stack up.
People with chronic kidney disease are at the highest risk because their kidneys already have reduced capacity to excrete potassium. Any further suppression of aldosterone or reduction in filtration can tip the balance. Similarly, people taking other medications that raise potassium (ACE inhibitors, ARBs, potassium-sparing diuretics, or trimethoprim) face compounded risk when an NSAID is added. The combination of an ACE inhibitor and an NSAID is particularly common and particularly risky, since both suppress the renin-angiotensin-aldosterone system through different mechanisms.
Older adults, people with diabetes (which can independently cause low aldosterone through kidney damage), and those with heart failure are also at elevated risk. Dehydration magnifies the problem by making the kidneys more dependent on prostaglandins to maintain blood flow.
What Hyperkalemia Feels Like
Mild elevations in potassium often cause no symptoms at all, which is part of what makes this dangerous. As levels climb, you may notice muscle weakness, fatigue, or a tingling or numb feeling in your extremities. Higher levels can cause nausea and an irregular heartbeat. Severe hyperkalemia is a medical emergency because it can trigger life-threatening heart rhythm disturbances. The heart is exquisitely sensitive to potassium levels, and even modest elevations above 6.0 mEq/L can show up as changes on an electrocardiogram.
If you’re taking NSAIDs regularly and you have any of the risk factors listed above, periodic blood tests to check potassium levels are a reasonable precaution, especially within the first few weeks of starting the medication or after a dose increase.